Dear readers,
After eight years of writing about topics such as excessiveness, liability standards, and trial strategies, we’ve decided to retire Guideposts.
Rest assured that Mayer Brown will continue to share its analysis of litigation topics via Legal Updates, webinars
On March 11, I joined Tiger Joyce, President of the American Tort Reform Association, and Dan Mehan, President and CEO of the Missouri Chamber of Commerce and Industry, in a Washington Legal Foundation webinar about the issues raised in a
Adding to the list of sad things that happened in 2020, my long-time friend and mentor Andy Frey retired from Mayer Brown at the end of the year. Although Andy will remain available to consult on punitive damages and other
Ordinarily, a ratio of 25:1 would ring the death knell for a punitive damages award. But just as a 1:1 ratio is not always a safe harbor, a double-digit ratio is not always indicative of a punitive award that exceeds
Making important law on the question of vicarious liability for punitive damages, the Fourth Circuit recently reversed awards of punitive damages under Title VII and North Carolina law in Ward v. AutoZoners.
The case involved alleged peer-on-peer sexual harassment
Last week, I posted the first installment of a two-part series on recent excessiveness decisions. In this second installment, I discuss two additional excessiveness decisions.
In re: Volkswagen “Clean Diesel” Marketing, Sales Practices, & Products Liability Litigation
This case involves
During the past couple of months, courts have been busy addressing excessiveness challenges to punitive damages awards. In this post, I discuss two recent decisions. In a second post, I will cover two additional decisions.
Ramirez v. TransUnion LLC
This
Last summer, my colleague C.J. Summers and I posted a report about Saccameno v. U.S. Bank National Association, a Seventh Circuit case in which we had filed an amicus brief on behalf of the Chamber of Commerce of the United
Last October, I reported on the $8 billion punitive verdict returned by a Philadelphia jury against Johnson & Johnson in a case alleging that the company had failed to warn that its antipsychotic drug Risperdal could cause young men to
By now, you’ve probably read reports of the $8 billion punitive verdict against Johnson & Johnson in an individual case alleging failure to warn that young men using its antipsychotic drug Risperdal could develop breasts. Robot-like, virtually every article about
